Copper Storage Liver Disease in Dogs (Copper-Associated Hepatopathy)

Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Copper storage hepatopathy, also known as Wilson’s disease in dogs, is a genetic condition characterized by the abnormal accumulation of copper in the liver. This leads to liver damage and, if left untreated, can cause severe health problems.

The most important facts at a glance

Copper storage hepatopathy, also known as Wilson’s disease in dogs, is a genetic condition that occurs mainly in certain breeds such as Bedlington Terriers, West Highland White Terriers, and Doberman Pinschers. These dogs have difficulty excreting copper from the liver, leading to accumulation. Excess copper amounts cause oxidative stress and cell damage in the liver, which can lead to Inflammatory conditions and fibrosis. Symptoms of the disease include loss of appetite, Vomiting, Diarrhea, lethargy, and jaundice. In severe cases, neurological symptoms and coagulopathies may occur.

Diagnosis is made through clinical examinations, laboratory analyses, and imaging procedures. A liver biopsy is often necessary to determine the copper content directly. Treatment includes a low-copper diet and medications that promote copper excretion. Antioxidants can help protect the liver. The prognosis depends on the stage of the disease at diagnosis; early detection improves the chances of a good outcome.

Prevention focuses on genetic testing in breeding to identify and exclude affected dogs. For dogs with a genetic predisposition, a low-copper diet is essential. Regular veterinary examinations are important to intervene early if signs of the disease appear. A comprehensive approach that considers both genetic and environmental factors is crucial to minimize the risk of the disease.

Causes

The disease is genetic and often occurs in certain dog breeds, including Bedlington Terriers, West Highland White Terriers, and Doberman Pinschers. These breeds have genetic predispositions that impair their ability to eliminate copper from the liver.

Normally, copper absorbed through food is stored in the liver and used as needed or excreted from the body. In dogs with copper storage hepatopathy, this mechanism is disrupted, causing copper to accumulate in the liver. This accumulation leads to oxidative stress and cell damage, which can ultimately result in liver inflammation and fibrosis.

The genetic basis of the disease varies by breed. In Bedlington Terriers, a specific genetic trait has been identified that is responsible for copper accumulation. In other breeds, the genetic basis is not yet fully understood, but there are indications that multiple genes may be involved.

Environmental factors can also play a role in the severity of the disease. A copper-rich diet can worsen the disease, especially in genetically predisposed dogs. Therefore, managing copper intake is an important aspect of disease control.

Symptoms

Symptoms of copper storage hepatopathy can vary depending on the stage of the disease and the severity of copper accumulation. The most common signs include loss of appetite, Weight loss, lethargy, and Vomiting. These symptoms are non-specific and can easily be confused with other liver diseases.

In advanced stages, dogs may develop jaundice, characterized by yellowing of the skin and mucous membranes. This is a sign that the liver is severely impaired and can no longer effectively process bilirubin, a waste product of hemoglobin breakdown.

Neurological symptoms can also occur when liver function is severely impaired. These may include Behavioral changes, coordination problems, and, in severe cases, seizures. These symptoms are often an indication of advanced liver disease and require immediate veterinary care.

Diagnosis

Diagnosing copper storage hepatopathy requires a combination of clinical examinations, laboratory tests, and imaging procedures. A thorough medical history and physical examination are the first step in making a suspected diagnosis. The veterinarian will ask about the specific symptoms and the dog’s breed.

Blood tests are essential to assess liver function. Elevated liver enzymes, bilirubin, and specific copper values can indicate the disease. However, definitive proof of copper accumulation can only be obtained through a liver biopsy. With this invasive method, a small sample of liver tissue is taken and tested for copper content.

Imaging methods such as ultrasound or CT scans can be helpful to assess the condition of the liver and rule out other possible causes of the symptoms. These methods are non-invasive and provide valuable information about the structure of the liver.

Therapy

Treatment for copper storage hepatopathy aims to reduce copper accumulation in the liver and control symptoms. A special low-copper diet is often the first step. This diet helps prevent further copper buildup and slows disease progression.

Medications that promote copper excretion are also an essential part of therapy. Penicillamine and trientine are chelating agents that help remove copper from the body. However, these medications can have side effects and must be dosed under veterinary supervision.

Antioxidants such as vitamin E and S-adenosylmethionine (SAMe) may also be considered to reduce oxidative stress in the liver. These supplements can help protect liver cells from further damage.

In severe cases where liver function is significantly impaired, supportive therapy may be necessary. This may include administering fluids and electrolytes, as well as treating complications such as infections or neurological disorders.

Prognosis and follow-up care

The prognosis for dogs with copper storage hepatopathy depends on various factors, including the stage of the disease at the time of diagnosis, the breed, and the response to treatment. With early diagnosis and appropriate therapy, the prognosis can be favorable, and many dogs can achieve a good quality of life.

However, dogs diagnosed at an advanced stage of the disease have a poorer prognosis. The liver damage may be irreversible, and treatment often focuses on relieving symptoms and improving quality of life.

Long-term follow-up and regular veterinary check-ups are crucial to monitor disease progression and adjust treatment accordingly. With proper care, many dogs can live a relatively normal life despite the diagnosis.

Prevention

Because copper storage hepatopathy is genetic, prevention focuses on responsible breeding practices. Breeders should have genetic tests performed to identify affected dogs and exclude them from breeding. This can help reduce the spread of the disease in the population.

For dogs that already have a genetic predisposition, controlling copper intake is crucial. A low-copper diet can help prevent copper accumulation in the liver. Veterinarians can recommend special diets tailored to the dog’s needs.

Regular veterinary examinations are important to detect early signs of the disease. Blood tests and, if necessary, liver biopsies can help monitor liver function and intervene early if abnormalities are detected.

Overall, prevention requires a holistic approach that considers both genetic and environmental factors. By understanding the disease and working with a veterinarian, dog owners can help minimize the risk of developing copper storage hepatopathy.

Frequently asked questions (FAQs)

1. What is copper storage hepatopathy?
Copper storage hepatopathy is a liver disease in which copper accumulates excessively in liver cells. Copper is normally an essential trace element, but in excess concentrations it is cytotoxic and leads to chronic hepatitis, fibrosis and ultimately liver cirrhosis. The disease resembles Wilson's disease in humans.
2. Which breeds are particularly affected?
Bedlington Terriers are classically affected with a mutation in the COMMD1 gene that severely impairs copper excretion. Labrador Retrievers (ATP7B variants), Doberman, West Highland White Terrier, Dalmatian and Skye Terrier also show breed-associated copper overload. In other breeds, it occurs less commonly.
3. What symptoms develop?
Early stages are often asymptomatic. With progressive liver damage, non-specific signs such as anorexia, vomiting, weight loss, lethargy and polydipsia appear. In late stages, jaundice, ascites and hepatic encephalopathy with neurologic signs develop. Bedlington Terriers can also present with acute hemolytic crises.
4. How is the diagnosis made?
Elevated liver enzymes, especially ALT and alkaline phosphatase, are the first clue. Definitive diagnosis is by liver biopsy with quantitative measurement of liver copper. Values above 400 to 1000 µg/g dry weight are pathologic. In predisposed breeds, gene tests are available and useful.
5. How is the disease treated?
Copper chelators such as D-penicillamine or trientine bind copper and promote its excretion in urine. A copper-restricted diet is fed and zinc is given to reduce intestinal copper absorption. With existing hepatitis, hepatoprotectants such as S-adenosylmethionine, silymarin and ursodeoxycholic acid are added.
6. What does a copper-restricted diet look like?
Specialized commercial liver diets are suitable. Copper-rich foods such as liver, organ meats, shellfish, chocolate, nuts and legumes should be avoided. Drinking water should also be low in copper, especially with old copper plumbing. Copper intake should remain below 1 mg per 1000 kcal.
7. Can the disease be cured?
In Bedlington Terriers, the genetic cause is not curable, but copper can be removed successfully over years. In other breeds, prognosis depends on stage. In early phases, liver values and histology can improve markedly with consistent therapy. Established cirrhosis is not reversible.
8. How often are check-ups needed?
Initially, checks every four to six weeks are useful, later every three to six months. Clinical assessment, liver values and possibly repeat biopsies are used to evaluate response. Serum zinc levels and urinary copper excretion can also be monitored.
9. What is the breeding relevance?
In the Bedlington Terrier, gene testing is established and indispensable to avoid mating two carriers. In other breeds with familial clustering, affected dogs and their relatives should not be used for breeding. Breeding programs with structured liver work-ups have markedly reduced prevalence in the Bedlington Terrier.
10. How does the disease differ from other chronic hepatitides?
Chronic hepatitis can have many causes, including infections, autoimmune reactions, drugs or toxins. Demonstration of markedly elevated copper in liver biopsy is the decisive distinguishing feature. Breed, age and clinical picture provide important clues but do not replace histologic and quantitative analysis.